Safety and Efficacy Study of Autologous Bone Marrow Derived Stem Cell Treatment in Amyotrophic Lateral Sclerosis
Clinical trial NCT01363401 · COMPLETED
Trial details
- NCT number
- NCT01363401
- Sponsor
- Corestemchemon, Inc.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-02-01
- Primary completion
- 2013-05-01
- Enrollment
- 72
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.